BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 31561892)

  • 1. Differentiated and exponentially growing HL60 cells exhibit different sensitivity to some genotoxic agents in the comet assay.
    Montag G; Bankoglu EE; Bolte A; Hintzsche H; Djelic N; Stopper H
    Mutat Res Genet Toxicol Environ Mutagen; 2019 Sep; 845():402972. PubMed ID: 31561892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell survival after DNA damage in the comet assay.
    Bankoglu EE; Schuele C; Stopper H
    Arch Toxicol; 2021 Dec; 95(12):3803-3813. PubMed ID: 34609522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of Styrax camporum and of Chemical Markers (Egonol and Homoegonol) on DNA Damage Induced by Mutagens with Different Mechanisms of Action.
    de Oliveira PF; Damasceno JL; Nicolella HD; Bertanha CS; Pauletti PM; Tavares DC
    Biol Pharm Bull; 2016; 39(11):1839-1845. PubMed ID: 27803455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of alkylator (melphalan) resistance in HL60 cells is accompanied by increased levels of topoisomerase II expression and function.
    Pu QQ; Bezwoda WR
    Mol Pharmacol; 1999 Jul; 56(1):147-53. PubMed ID: 10385695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction and repair of DNA damage measured by the comet assay in human T lymphocytes separated by immunomagnetic cell sorting.
    Bausinger J; Speit G
    Mutat Res; 2014 Nov; 769():42-8. PubMed ID: 25771724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baccharin prevents genotoxic effects induced by methyl methanesulfonate and hydrogen peroxide in V79 cells.
    de Oliveira PF; Leandro LF; Montanheiro G; Bastos JK; da Silva Filho AA; Tavares DC
    J Food Sci; 2012 Aug; 77(8):T138-42. PubMed ID: 22860599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular effects of topoisomerase II inhibitors in AML cell lines: correlation of apoptosis with topoisomerase II activity but not with DNA damage.
    Gieseler F; Bauer E; Nuessler V; Clark M; Valsamas S
    Leukemia; 1999 Nov; 13(11):1859-63. PubMed ID: 10557063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A combination of in vitro comet assay and micronucleus test using human lymphoblastoid TK6 cells.
    Kimura A; Miyata A; Honma M
    Mutagenesis; 2013 Sep; 28(5):583-90. PubMed ID: 23863314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. hOGG1 recognizes oxidative damage using the comet assay with greater specificity than FPG or ENDOIII.
    Smith CC; O'Donovan MR; Martin EA
    Mutagenesis; 2006 May; 21(3):185-90. PubMed ID: 16597659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotoxicity of environmental agents assessed by the alkaline comet assay.
    Møller P
    Basic Clin Pharmacol Toxicol; 2005; 96 Suppl 1():1-42. PubMed ID: 15859009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of bixin on DNA damage and cell death induced by doxorubicin in HL60 cell line.
    Santos GC; Almeida MR; Antunes L; Bianchi M
    Hum Exp Toxicol; 2016 Dec; 35(12):1319-1327. PubMed ID: 26860686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of HepG2 cell line for direct or indirect mutagens screening: comparative investigation between comet and micronucleus assays.
    Valentin-Severin I; Le Hegarat L; Lhuguenot JC; Le Bon AM; Chagnon MC
    Mutat Res; 2003 Apr; 536(1-2):79-90. PubMed ID: 12694748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotoxicity of alkene epoxides in human peripheral blood mononuclear cells and HL60 leukaemia cells evaluated with the comet assay.
    Fabiani R; Rosignoli P; De Bartolomeo A; Fuccelli R; Morozzi G
    Mutat Res; 2012 Aug; 747(1):1-6. PubMed ID: 22285587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism-based chemopreventive strategies against etoposide-induced acute myeloid leukemia: free radical/antioxidant approach.
    Kagan VE; Yalowich JC; Borisenko GG; Tyurina YY; Tyurin VA; Thampatty P; Fabisiak JP
    Mol Pharmacol; 1999 Sep; 56(3):494-506. PubMed ID: 10462537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA oxidative damage during differentiation of HL-60 human promyelocytic leukemia cells.
    Covacci V; Torsello A; Palozza P; Sgambato A; Romano G; Boninsegna A; Cittadini A; Wolf FI
    Chem Res Toxicol; 2001 Nov; 14(11):1492-7. PubMed ID: 11712906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An in vivo comet assay of multiple organs (liver, kidney and bone marrow) in mice treated with methyl methanesulfonate and acetaminophen accompanied by hematology and/or blood chemistry.
    Oshida K; Iwanaga E; Miyamoto-Kuramitsu K; Miyamoto Y
    J Toxicol Sci; 2008 Dec; 33(5):515-24. PubMed ID: 19043273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis induced by DNA topoisomerase I and II inhibitors in human leukemic HL-60 cells.
    Solary E; Bertrand R; Pommier Y
    Leuk Lymphoma; 1994 Sep; 15(1-2):21-32. PubMed ID: 7858500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncofetal HMGA2 attenuates genotoxic damage induced by topoisomerase II target compounds through the regulation of local DNA topology.
    Ahmed SM; Dröge P
    Mol Oncol; 2019 Oct; 13(10):2062-2078. PubMed ID: 31271486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between the DNA-binding affinity of topoisomerase inhibiting drugs and their capacity to induce hematopoetic cell differentiation.
    Gieseler F; Boege F; Clark M; Meyer P
    Toxicol Lett; 1993 Apr; 67(1-3):331-40. PubMed ID: 8383890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the in vitro and in vivo genotoxic and antigenotoxic effects of pimaradienoic acid in mammalian cells.
    Kato FH; Viana NI; Santini CB; de Souza CG; Veneziani RC; Ambrósio SR; Tavares DC
    Mutat Res; 2012 Dec; 749(1-2):87-92. PubMed ID: 22985806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.